Hopital Necker
Paris, 75015, France
NCT Number: NCT01022957
to describe evolution of Nephronophthisis
Looking for future studies?
Notify Me7 year and older
All sexes
Interventional
Not applicable
Paris, 75015, France
To specify the long term evolution of Nephronophthisis in terms of renal disease as well as extra-renal damages for patients having a confirmed diagnosis of NPHP1, NPHP2, NPHP3, NPHP4, NPHP5, NPHP6 or NPHP8 gene mutation
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
to determine the long term evolution of Nephronophthisis in terms of renal disease as well as extra-renal damages for patients having a confirmed diagnosis of NPHP1, NPHP2, NPHP3, NPHP4, NPHP5, NPHP6 or NPHP8 gene mutation
Time frame: start from the first time of clinical diagnosis to now
Assistance Publique - Hôpitaux de Paris
Other
Characterization and Analysis of Long-term Evolution of Renal and Extra-renal Damages in the Course of Nephronophthisis
Acronym: NEPHAER
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04874909
Abnormalities, Multiple, Agenesis of Cerebellar Vermis
Paris, France
View Trial DetailsNCT05286632
Abnormalities, Multiple, Albuminuria
Bari, Italy
View Trial DetailsNCT01401998
Abnormalities, Multiple, Agenesis of Cerebellar Vermis
Washington D.C., District of Columbia, United States
View Trial DetailsNCT06648044
Autosomal, Disease
La Defense, France
View Trial Details